Litcius/Paper detail

Efficacy and safety of moxidectin compared with ivermectin against Strongyloides stercoralis infection in adults in Laos and Cambodia: a randomised, double-blind, non-inferiority, phase 2b/3 trial

Viviane Sprecher, Daniela Hofmann, Vanthanom Savathdy, Phengsavanh Xayavong, Chomseng Norkhankhame, Rekol Huy, Virak Khieu, Somphou Sayasone, Jan Hattendorf, Jennifer Keiser

2023The Lancet Infectious Diseases16 citationsDOI

Topics & Concepts

IvermectinMoxidectinMedicinePlaceboPopulationClinical endpointRandomized controlled trialStrongyloides stercoralisInternal medicineVeterinary medicineImmunologyHelminthsEnvironmental healthAlternative medicinePathologyParasites and Host InteractionsParasitic Diseases Research and TreatmentHelminth infection and control
Efficacy and safety of moxidectin compared with ivermectin against Strongyloides stercoralis infection in adults in Laos and Cambodia: a randomised, double-blind, non-inferiority, phase 2b/3 trial | Litcius